Categories

Industry News

Blood Testing Market Surpasses USD 2 Billion in 2016

By Labmedica International staff writers
16 Jun 2017

Image: The global market for blood testing and typing products reached USD 2.6 billion in 2016 (Photo courtesy of iStock).The global market for blood testing and typing products used in blood banking/donations of pooled blood reached USD 2.6 billion in 2016, although blood banking is not a fast-growing market and tends to grow only when new diseases are added to testing menu. These are the latest findings of Kalorama Information (New York, NY, USA), an independent medical market research firm.

In its study of the testing markets amidst increased vigilance by U.S. health authorities and cases of Zika and other diseases, Kalorama found three common types of tests related to blood banking:

Immunoassays for HIV, hepatitis B, hepatitis C and syphilis are routinely used to test blood units for blood borne infectious agents. In Latin America, all blood banks also screen donated units for Chagas disease while in some developing countries, blood banks undertake additional screening for Dengue fever and malaria, which are common and deadly in several tropical nations.

Blood grouping and typing reagents and instruments are used by blood transfusion services, hospital and private blood banks and hospital laboratories that prepare blood units for transfusion to patients. Blood bank lab systems require blood tracking to avoid the possibility of the serious error of administering the wrong blood type to a patient.

Nucleic acid testing (NAT) allows blood banks to detect viral contamination, including West Nile Virus, HIV and hepatitis C, sooner and stop them from slipping into blood transfusions, thus making NAT an integral part of efforts to make blood transfusions safer. An estimated 53 million units of blood are screened using NAT. The commonly used NAT assays detect HIV-1 RNA, HCV RNA, HBV DNA, and West Nile Virus (WNV) RNA, and are used to test for West Nile virus, HIV and HCV in almost all the blood drawn in North America, Europe and Japan.

“Although no dramatic change in the testing industry is expected, new guidelines and disease concerns make it a worthwhile time for business planners to revisit test market assumptions,” said Bruce Carlson, Publisher of Kalorama Information.

Related Links:
Kalorama Information



E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

16 Jun 2017
Transasia Showcases Clinical Lab Solutions at APPI 2017
Transasia Bio-Medicals Ltd., an in-vitro diagnostic company, will be the technology partner as well as principal partner of the 4th Annual Conference hosted by the Association of Practicing Pathologists of India (APPI-Mumbai), held June 16-18, 2017, in Mumbai, India.
Read More
14 Jun 2017
Siemens Healthineers and Fast-track Diagnostics Form Strategic Relationship
Siemens Healthineers, the separately managed healthcare business of Siemens AG, has entered into a new strategic relationship with Fast-track Diagnostics for the addition of FTD’s broad range of CE-marked kits and multi-syndromic panels to the menu of Siemens Healthineers’ VERSANT kPCR Molecular System. This will allow Siemens Healthineers to provide its customers with expanded, more comprehensive molecular testing solutions.
Read More
14 Jun 2017
Grifols and Beckman Coulter Enter Distribution Agreement
Healthcare company Grifols, which produces plasma-derived medicines and also develops diagnostic solutions, and Beckman Coulter Inc., a provider of diagnostics solutions, have entered into an exclusive, long-term agreement for the worldwide distribution of Grifols’ hemostasis instruments, reagents and consumables.
Read More
08 Jun 2017
Toshiba’s First Infinix-i 4DCT Installed in France Hospital
Toshiba Medical’s Infinix-i 4DCT room has been in installed by the Montpellier University Hospital in France, making it the first in Europe to combine a new generation angiography room, a 640 slice 4D CT scanner moving on a sophisticated rail concept and a widescreen display. The interventional radiology intervention room installed in the Department of Interventional Radiology at the St-Eloi Hospital for the treatment of liver tumors is the 11th in the world (7th in Japan, 2nd in Korea, and 1st in the US) to integrate such advanced technology.
Read More
05 Jun 2017
Global Robotic Lab Systems Market Reaches USD 8.8 Billion
The size of the global robotic laboratory automation systems market has reached USD 8.8 billion, with its future growth likely to be driven by an imbalance between the high demand for diagnostics and the lack of supply of qualified technicians. These are the latest findings of Kalorama Information, (New York, NY, USA), an independent medical market research firm.
Read More
05 Jun 2017
Sysmex Corporation to Acquire Oxford Gene Technology
Sysmex Corporation (Kobe, Japan), an in vitro diagnostic company, has entered into an agreement to acquire molecular genetics company, Oxford Gene Technology (OGT; Begbroke, Oxfordshire, U.K).
Read More
01 Jun 2017
TeraRecon Acquires McCoy Medical Technologies
TeraRecon, a provider of advanced visualization and enterprise medical image viewing solutions, has announced the acquisition of machine learning company, McCoy Medical Technologies.
Read More
30 May 2017
Stago Group Acquires HemoSonics
The Stago Group, which develops and markets automated systems for blood analysis in coagulation, has completed the acquisition of HemoSonics LLC, a developer of point-of-care (POC) testing solutions.
Read More
30 May 2017
Richardson Electronics Sells PACS Business to Double Black Imaging
Richardson Electronics, Ltd. has sold its picture archiving and communication systems (PACS) display business to Double Black Imaging.
Read More
Copyright © 2000-2017 TradeMed.com. All rights reserved. | Terms And Conditions